Transgene sells Tasly its stake in Transgene Tasly (Tianjin) JV
Transgene SA is selling Tasly Biopharmaceuticals Co. Ltd. its 50% stake of their equally owned Transgene Tasly (Tianjin) BioPharmaceutical Co. virus-based immunotherapies joint venture (formed in 2010), giving Tasly a 100% ownership of the JV.
- Large Molecule
- Acquisition of Private Biotech
- Intra-Biotech Deal
- Partial Acquisition
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com